Table 1.
Controls | PD | p-Value | |
---|---|---|---|
N | 50 | 95 | |
% Female | 38 | 32 | |
Age (years) | 67.8 (8.0) | 68.7 (7.7) | 0.947 |
Height (cm) | 171.7 (9.8) | 174.2 (10.2) | 0.176 |
Mass (kg) | 73.8 (14.6) | 79.5 (15.2) | 0.033 |
miniBEST | 24.6 (2.2) | 18.4 (4.7) | <0.001 |
TUG time (s) | 18.3 (3.1) | 23.2 (10.0) | 0.001 |
MoCA | 26.8 (1.9) | 25.5 (3.6) | 0.019 |
SCOPA-COG | 32.0 (3.5) | 28.1 (5.6) | <0.001 |
Fall in the past year (%) | 12 | 38 | |
Disease duration (years) | – | 7.0 (5.2) | |
MDS-UPDRS part III | – | 40.4 (12.9) | |
PIGD score | – | 5.0 (3.2) | |
H&Y (range) | – | 2–3 | |
N with freezing of gait | – | 26 |
Where applicable, groups were compared using independent sample t-tests and a significance level of 0.05.
Bold values indicate significant differences between PD and control subjects.
PD, Parkinson’s disease; miniBEST, mini Balance Evaluation Systems Test; MoCA, Montreal Cognitive Assessment; PIGD, Posture Instability and Gait Disability.